AGN92013/ALRT1057 FOR RETINAL DETACHMENT DUE TO PROLIFERATIVE VITREORETINOPATHY

AGN92013/ALRT1057 用于治疗增殖性玻璃体视网膜病变引起的视网膜脱离

• 批准号: 6274426
• 负责人: PAUL STERNBERG
• 金额: $ 3.57万
• 依托单位: EMORY UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 1997
• 资助国家: 美国
• 起止时间: 1997-12-01 至 1998-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6274426
• 关键词: clinical research; combination chemotherapy; eye disorder chemotherapy; human subject; human therapy evaluation; placebos; postoperative state; proliferative vitreoretinopathy; retina detachment

This is a multicenter, double-masked, randomized, placebo-controlled, pilot safety and efficacy study of 8 weeks postoperative treatment with AGN 192013/ ALRT1057 in patients with retinal detachment due to proliferative vitreoretinopathy (PVR). This study seeks to determine if the drug results in an incidence of retinal detachment, posterior to the buckle, which is at least 10% less than the incidence for patients treated with placebo.

这是一个多中心、双盲、随机、安慰剂对照的试验